High-Throughput Screening to Identify Compounds That Increase Fragile X Mental Retardation Protein Expression in Neural Stem Cells Differentiated From Fragile X Syndrome Patient-Derived Induced Pluripotent Stem Cells.
about
The Application of Human iPSCs in Neurological Diseases: From Bench to BedsideA Dishful of a Troubled Mind: Induced Pluripotent Stem Cells in Psychiatric ResearchInduced pluripotent stem cells for modeling neurological disordersDysregulation and restoration of translational homeostasis in fragile X syndromeDetection and Quantification of the Fragile X Mental Retardation Protein 1 (FMRP)Modeling Fragile X Syndrome Using Human Pluripotent Stem CellsUtility of Induced Pluripotent Stem Cells for the Study and Treatment of Genetic Diseases: Focus on Childhood Neurological DisordersRapid generation of sub-type, region-specific neurons and neural networks from human pluripotent stem cell-derived neurospheres.Concise Review: Progress and Challenges in Using Human Stem Cells for Biological and Therapeutics Discovery: Neuropsychiatric Disorders.One-Step Seeding of Neural Stem Cells with Vitronectin-Supplemented Medium for High-Throughput Screening Assays.Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.The translational potential of human induced pluripotent stem cells for clinical neurology : The translational potential of hiPSCs in neurology.Human pluripotent stem cell models of Fragile X syndrome.A Set of Assays for the Comprehensive Analysis of FMR1 Alleles in the Fragile X-Related Disorders.Modeling simple repeat expansion diseases with iPSC technology.Human pluripotent stem cells in modeling human disorders: the case of fragile X syndrome.Induced pluripotent stem cell technology: a decade of progress.Human induced pluripotent stem cells for modelling neurodevelopmental disorders.Modelling Autistic Neurons with Induced Pluripotent Stem Cells.Establishment of Reporter Lines for Detecting Fragile X Mental Retardation (FMR1) Gene Reactivation in Human Neural Cells.A Rapid Pipeline to Model Rare Neurodevelopmental Disorders with Simultaneous CRISPR/Cas9 Gene Editing.Autism spectrum disorders and disease modeling using stem cells.Recent advances in assays for the fragile X-related disorders.Stem Cell Technology for (Epi)genetic Brain Disorders.Uncovering True Cellular Phenotypes: Using Induced Pluripotent Stem Cell-Derived Neurons to Study Early Insults in Neurodevelopmental Disorders.
P2860
Q26765876-AC4087E3-EF92-498D-A14E-3A959C89736FQ26770097-610DC6AF-8390-486D-9CF9-747056D228A2Q26771402-D9ACA82F-5936-43B1-9EB9-12A523197B76Q26782616-690C48BD-A298-472C-B4CC-E2717758D380Q28079967-085EA47A-A9F6-4575-9400-9EDACF38D1F3Q28080022-EDECADBA-E12D-4D11-9D4F-2DE046366E20Q28080219-83201079-9355-4497-A7D3-725435702EA1Q36421297-68A3EBCE-225B-4255-BC6C-28CB5391DF5CQ36717285-4A59032A-48BC-40C3-9016-19189DEF67FEQ37617276-42A25D0A-A8D4-4D0D-BF5A-6ED4A740ECEEQ37624658-549EAE81-37F3-4346-A24B-B891E2C999C3Q37666286-B65417CD-D894-4EE3-82BA-258D5B4EBE7CQ38660520-93301379-209F-4393-81F8-C1639CCF9AC9Q38751622-06BC52FD-A1AB-43AD-89A3-9D85BFAB049FQ38853911-ECBE695E-C0B3-4F2A-806C-0CC2BB503E8FQ39024323-C53DF88E-97EF-4F42-BEBF-E6C8D7ACDA16Q39040578-B3B2D089-C877-4D5A-80EA-DD3A7D745B0DQ39247913-AEF9ABAA-31D1-4EA3-814D-C8A6B84C2945Q39334479-32A1D067-3DF4-4264-A6E7-BA80824C3BFEQ39597255-06FCE816-B543-40FE-871C-13978FEF14EEQ42247782-A3D4852C-8825-488E-B021-C4F76F780D24Q46142342-AD9F50EE-6E62-4E03-868E-6BF8FCDA6A7BQ47630636-7ECE9D7C-C45E-48AF-9C94-666DD5B91A1EQ47718746-9DC82642-0F63-4921-B60C-9035E9C0A629Q54961637-F3C92B47-CD89-43B2-A6E1-A2DBF957772E
P2860
High-Throughput Screening to Identify Compounds That Increase Fragile X Mental Retardation Protein Expression in Neural Stem Cells Differentiated From Fragile X Syndrome Patient-Derived Induced Pluripotent Stem Cells.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
High-Throughput Screening to I ...... nduced Pluripotent Stem Cells.
@ast
High-Throughput Screening to I ...... nduced Pluripotent Stem Cells.
@en
type
label
High-Throughput Screening to I ...... nduced Pluripotent Stem Cells.
@ast
High-Throughput Screening to I ...... nduced Pluripotent Stem Cells.
@en
prefLabel
High-Throughput Screening to I ...... nduced Pluripotent Stem Cells.
@ast
High-Throughput Screening to I ...... nduced Pluripotent Stem Cells.
@en
P2093
P2860
P356
P1476
High-Throughput Screening to I ...... nduced Pluripotent Stem Cells.
@en
P2093
Daman Kumari
Karen Usdin
Manju Swaroop
Wenwei Huang
P2860
P304
P356
10.5966/SCTM.2014-0278
P577
2015-05-21T00:00:00Z